The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: A case-control study

Journal of Nutritional Biochemistry

Volumn 24, Issue 5, 2013, Pages 803-808

  Lee, Lai Kuan ^a,b   Shahar, Suzana ^a   Rajab, NorFadilah ^a   Yusoff, Noor Aini Mohd ^c   Jamal, Rahman A ^d   Then, Sue Mian ^d  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b SCHOOL OF HEALTH SCIENCES   (Malaysia)

^c Masterskill University College of Health Sciences   (Malaysia)

^d UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Lipid peroxidation; Mild cognitive impairment; Polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LIPID HYDROPEROXIDE; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FOOD FREQUENCY QUESTIONNAIRE; GENOTYPE; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MILD COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION;

AGED; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FEMALE; GENOTYPE; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; RISK FACTORS;

EID: 84876803871     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.04.014     Document Type: Article

References (44)

1. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004, 3:240-246.
2. Baldeiras I., Santana I., Proenc M.T., Garrucho M.H., Pascoal R., Rodrigues A., et al. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease. J Alzheimer's Dis 2008, 15:117-128.
3. Padurariu M., Ciobicab A., Hritcu L., Stoicaa B., Bilda W., Stefanescu C. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 2010, 469:6-10.
4. Butterfield D.A., Castegna A., Pocernich C.B., Drake J., Scapagnini G., Calabrese V. Nutritional approaches to combat oxidative stress in Alzheimer's disease. J Nutr Biochem 2002, 13:444-461.
5. Markesbery W.R., Lovell M.A. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch Neurol 2007, 7:954-956.
6. Mangialasche F., Cristina Polidori M., Monastero R., Ercolani S., Camarda C., Cecchetti R., et al. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Research Rev 2009, 8:285-305.
7. Carini M., Aldini G., Facino R.M. Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins. Mass Spectrom Rev 2004, 4:281-285.
8. Yehuda E.S., Rabinovitz S., Carasso R.L., Mostofsky D.I. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002, 5:843-853.
9. Tai C.C., Ding S.T. N-3 polyunsaturated fatty acids regulate lipid metabolism through several inflammation mediators: mechanisms and implications for obesity prevention. J Nutr Biochem 2010, 21:357-363.
10. Lin Y.H., Shah S., Salem N. Altered essential fatty acid metabolism and composition in rat liver, plasma, heart and brain after microalgal DHA addition to the diet. J Nutr Biochem 2011, 22:758-765.
11. Richard D., Kefi K., Barbe U., Bausero P., Visioli F. Polyunsaturated fatty acids as antioxidants. Pharmacol Res 2008, 57:451-455.
12. Kameda K., Matsunaga T., Abe N., Hanada H., Ishizaka H., Ono H., et al. Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease: Possible role for left ventricular remodelling. Eur Heart J 2003, 24:2180-2185.
13. Wright S.A., O'Prey F.M., McHenry M.T., Leahey W.J., Devine A.B., Duffy E.M., et al. A randomised interventional trial of omega-3 polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus. Ann Rheum Dis 2008, 67:841-848.
14. Mazière C., Dantin F., Conte M.A., Deqonville J., Ali D., Dubois F., et al. Polyunsaturated fatty acid enrichment enhances endothelial cell-induced low-density-lipoprotein peroxidation. Biochem J 1998, 336:57-62.
15. Roberts R.O., Cerhan J.R., Geda Y.E., Knopman D.S., Cha R.H., Christianson T.J.H., et al. Polyunsaturated fatty acids and reduced odds of MCI: the Mayo Clinic Study of Aging. JAD 2010, 21:853-865.
16. Solfrizzi V., Frisardi V., Capurso C., D'Introno A., Colacicco A.M., Vendemiale G., et al. Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms. Ageing Res Rev 2010, 9:184-199.
17. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J Intern Med 2004, 256:183-194.
18. Lee L.K., Shahar S., Chin A.V., Mohammad Yusoff N.A., Rajab N.F., Aziz S. Prevalence of gender disparities and predictors affecting the occurrence of mild cognitive impairment (MCI). Arch Gerontol Geriatr 2012, 54:185-191.
19. Ibrahim N.M., Shohaimi S., Chong H.T., Abdul Rahman A.H., Razali R., Esther E., et al. Validation study of the Mini-Mental State Examination in a Malay-Speaking elderly population in Malaysia. Dement Geriatr Cogn Disord 2009, 27:247-253.
20. Mattis S. Dementia rating scale: professional manual 1988, Psychological Assessment Resources Inc, Odessa (Fla).
21. Rey A. L'examenclinique en psychologie 1964, Presses Universitaires de France, Paris.
22. Wechsler D. Wechsler Adult Intelligence Scale 1997, The Psychological Corporation, San Antonio (Tex). 3rd ed.
23. Sunderland T., Hill J.L., Mellow A.M., Lawlor B.A., Gundersheimer J., Newhouse P.A., et al. Clock drawing in Alzheimer's disease: a novel measure of dementia severity. J Am Geriatr Soc 1989, 37:725-729.
24. Tee E.S., Ismail M.N., Nasir M.A., Khatijah I. Nutrient composition of Malaysian foods 1997, Institute of Medical Research, Kuala Lumpur. 4th ed.
25. National Food Authority Composition of Foods, Australia (COFA), volume 7 1995, Australian Government Publishing Services, Canberra.
26. Hixson J., Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage by HhaI. J Lipid Res 1990, 31:545-548.
27. Martin-Gallan P., Carrascosa A., Gussinye M., Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003, 12:1563-1574.
28. van de Rest O., Geleijnse J.M., Kok F.J., van Staveren W.A., Dullemeijer C., Olderikkert M.G., et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 2008, 71:430-438.
29. Schaefer E.J., Bongard V., Beiser A.S., Lamon-Fava S., Robins S.J., Au R., et al. Plasma phosphatidylcholinedocosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 2006, 63:1545-1550.
30. Boudrault C., Bazinet R.P., Ma D.W.L. Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J Nutr Biochem 2009, 20:1-10.
31. Greilberger J., Koidl C., Greilberger M., Lamprecht M., Schroecksnadel K., Leblhuber F., et al. Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease. Free Radical Res 2008, 42:633-638.
32. Pratico D., Clark C.M., Liun F., Rokach J., Lee V.Y., Trojanowski J.Q. Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol 2002, 59:972-976.
33. Keller J.N., Schmitt F.A., Scheff S.W., Ding Q., Chen Q., Butterfield D.A., et al. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005, 64(7):1152-1156.
34. Butterfield D.A., Reed T., Perluigi M., De Marco C., Coccia R., Cini C., et al. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett 2006, 397:170-173.
35. Williams T.I., Lynn B.C., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging 2006, 27:1094-1099.
36. Su H.M. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. J Nutr Biochem 2010, 21:364-373.
37. Hossain M.S., Hashimoto M., Masumura S. Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia. Neurosci Lett 1998, 244:157-160.
38. Kubo K., Saito M., Tadokoro T., Maekawa A. Dietary docosahexaenoic acid dose not promote lipid peroxidation in rat tissue to the extent expected from peroxidizability index of the lipids. Biosci Biotech Bioch 1998, 62:1698-1706.
39. Yavin E., Brand A., Green P. Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr Neurosci 2002, 5:149-157.
40. Hossain M.S., Hashimoto M., Gamoh S., Masumura S. Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats. J Neurochem 1999, 72:1133-1138.
41. Cunnane S.C., Plourde M., Pifferi F., Féart C., Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 2009, 48:239-256.
42. Bloomer R.J., Kabir M.M., Trepanowski J.F., Canale R.E., Farney T.M. A 21 day Daniel Fast improves selected biomarkers of antioxidant status and oxidative stress in men and women. Nutr Metab 2011, 8:17-25.
43. Saunders A.M., Hulette C., Welsh-Bohmer K.A., Schmechel D.E., Crain B., Burke J.R., et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996, 348:90-93.
44. Seet W.T., Tan J.A., Mary A., Tan S.Y. Apolipoprotein E genotyping in the Malay, Chinese and Indian ethnic groups in Malaysia - a study on the distribution of the different apoE allele and genotypes. Clinical Chimica Acta 2004, 340:201-205.